BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 2 Pharmacokinetics 2 (PHA503) calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:123670a7-c3af-4c43-aaa7-5310b9930a78
DTSTAMP:20251227T223043Z
DTSTART:20251002T140000Z
DTEND:20251002T150000Z
SUMMARY:PK 3.1 Introduction to the pharmacokinetics module in year 2 and pharmacokinetic Parameter Estimations preparation session
DESCRIPTION:Module - PHA503, Person delivering - Dagan and team
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:116bc40a-67ea-4e5e-a835-ef81fc783e9c
DTSTAMP:20251227T223043Z
DTSTART:20251007T090000Z
DTEND:20251007T100000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:9de52abe-de7f-43cf-8074-b59bb1a8cfdc
DTSTAMP:20251227T223043Z
DTSTART:20251007T100000Z
DTEND:20251007T110000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:a35b4920-4abf-486d-a18c-f8e317b6db77
DTSTAMP:20251227T223043Z
DTSTART:20251007T110000Z
DTEND:20251007T120000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:55e68643-eb3f-4b41-b7e7-fbc2c3648762
DTSTAMP:20251227T223043Z
DTSTART:20251016T090000Z
DTEND:20251016T100000Z
SUMMARY:PK 3.4  Blood Brain Barrier
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:Self paced
END:VEVENT
BEGIN:VEVENT
UID:92d5ed32-690a-4e00-b794-f5282ebde810
DTSTAMP:20251227T223043Z
DTSTART:20251017T140000Z
DTEND:20251017T150000Z
SUMMARY:PK 3.3 Pre-clinical PK and animal to human predictions
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:49d908cc-72e4-4564-bcad-bbefb3261918
DTSTAMP:20251227T223043Z
DTSTART:20251027T100000Z
DTEND:20251027T110000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:b69d233d-0b5f-499e-91c8-f0fc2a2fdfa0
DTSTAMP:20251227T223043Z
DTSTART:20251027T110000Z
DTEND:20251027T120000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:e9831cc3-7efa-4652-8a3f-783c2fcfeab1
DTSTAMP:20251227T223043Z
DTSTART:20251027T120000Z
DTEND:20251027T130000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:5fe5d220-6419-49a2-8619-fb1aaf79bce8
DTSTAMP:20251227T223043Z
DTSTART:20251030T120000Z
DTEND:20251030T130000Z
SUMMARY:PK 3.6 Introduction to topics for Thursday PM  Joint Drug devt and PK
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Self paced online
END:VEVENT
BEGIN:VEVENT
UID:d6d71359-6511-47db-8fda-bf7a503a9aeb
DTSTAMP:20251227T223043Z
DTSTART:20251030T140000Z
DTEND:20251030T150000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:Live online
END:VEVENT
BEGIN:VEVENT
UID:52fbfade-3010-4722-b082-5149c2eb70bd
DTSTAMP:20251227T223043Z
DTSTART:20251030T150000Z
DTEND:20251030T160000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:Live online
END:VEVENT
BEGIN:VEVENT
UID:cd163a7d-b55c-4e62-a863-50fd3cf59bae
DTSTAMP:20251227T223043Z
DTSTART:20251113T100000Z
DTEND:20251113T110000Z
SUMMARY:PK and drug development assignment drop in session
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Ateeq
LOCATION:Live online
END:VEVENT
BEGIN:VEVENT
UID:c5a2ad4d-6e40-4261-8ab7-5125635c173c
DTSTAMP:20251227T223043Z
DTSTART:20251113T110000Z
DTEND:20251113T120000Z
SUMMARY:PK 3.8 Pharmacogenomics
DESCRIPTION:Module - PHA503, Person delivering - Reya
LOCATION:Self paced online
END:VEVENT
BEGIN:VEVENT
UID:5d66f0e8-7fd3-4817-b811-42bb4d666a08
DTSTAMP:20251227T223043Z
DTSTART:20251113T120000Z
DTEND:20251113T130000Z
SUMMARY:PK 3.9 Bioequivalence 2
DESCRIPTION:Module - PHA503, Person delivering - Toqa
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:594e33eb-0243-47cf-8ffb-0fa95a28e17e
DTSTAMP:20251227T223043Z
DTSTART:20251205T140000Z
DTEND:20251205T150000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:6caa67fd-dff4-43aa-b517-d77f382cdb50
DTSTAMP:20251227T223043Z
DTSTART:20251205T150000Z
DTEND:20251205T160000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:100d290e-b3fb-40bb-b012-3315017fbef9
DTSTAMP:20251227T223043Z
DTSTART:20251208T100000Z
DTEND:20251208T110000Z
SUMMARY:PK 3.11 Pharmacokinetic Variability
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre A
END:VEVENT
BEGIN:VEVENT
UID:adbb855a-d7e5-43cd-8774-ee717b48d2c2
DTSTAMP:20251227T223043Z
DTSTART:20260108T140000Z
DTEND:20260108T150000Z
SUMMARY:PK 3.12  Introduction to PK modelling
DESCRIPTION:Module - PHA503, Person delivering - Prof. Joe Standing
LOCATION:Self-paced
END:VEVENT
BEGIN:VEVENT
UID:3209ed1f-2f5b-45cd-b89d-b4299ad66403
DTSTAMP:20251227T223043Z
DTSTART:20260108T150000Z
DTEND:20260108T160000Z
SUMMARY:PK 3.13  Introduction to Compartmental analysis
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:Live online
END:VEVENT
END:VCALENDAR
